CHYLOPERITONEUM AFTER GASTRECTOMY: IS IT A MANAGEABLE NIGHTMARE?

  • Bárbara Castro General Surgery Department, Centro Hospitalar Vila Nova de Gaia/Espinho, Portugal http://orcid.org/0000-0001-5164-9633
  • Catarina Ortigosa General Surgery Department, Centro Hospitalar Vila Nova de Gaia/Espinho, Portugal
  • Amélia Tavares General Surgery Department, Centro Hospitalar Vila Nova de Gaia/Espinho, Portugal
  • Fernando Viveiros General Surgery Department, Centro Hospitalar Vila Nova de Gaia/Espinho, Portugal
  • Manuel Oliveira General Surgery Department, Centro Hospitalar Vila Nova de Gaia/Espinho, Portugal

Abstract


Chylous ascites is a serious and rare complication after gastrectomy for gastric cancer. Most cases improve with conservative treatment, but substantial morbidity and mortality can be associated. We describe the case of a 48-year-old-male submitted to partial gastrectomy with D2 lymphadenectomy for gastric adenocarcinoma. Three days after starting a liquid diet, it was diagnosed a chyle fistula. Conservative treatment was started with improvement of the patient and he was discharged. After eighteen days, the patient was readmitted due to a large volume chyloperitoneum, requiring paracentesis. Medical treatment was reinstituted, with amelioration and dismissal of the patient. The patient returned to the emergency department due to abdominal pain and fever and was submitted to laparoscopic abdominal drainage. There was resolution of refractory ascites during hospitalization. Chylous ascites is a rare complication after radical resections for gastric cancer. Therefore, there is no well-defined treatment and these cases remain a therapeutic challenge. The therapeutic strategies described include dietary measures, the use of pharmacological agents, total parenteral nutrition and, in selected cases, surgical or percutaneous interventions.

Downloads

Download data is not yet available.

References

1. Ilhan E, Demir U, Alemdar A, Ureyen O, Eryavuz Y, Mihmanli M. Management of high-output chylous ascites after D2-lymphadenectomy in patients with gastric cancer: a multi-center study. J Gastrointest Oncol. 2016;7(3):420-5.
2. Bhardwaj R, Vaziri H, Gautam A, Ballesteros E, Karimeddini D, Wu GY. Chylous Ascites: A Review of Pathogenesis, Diagnosis and Treatment. J Clin Transl Hepatol. 2018;6(1):105-13.
3. Kakinuma D, Kanazawa Y, Matsuno K, Masuda Y, Ando F, Hagiwara N, et al. Ligation and Fibrin Glue Spraying for Intractable Chylous Ascites after Radical Gastrectomy for Gastric Cancer: Case Report and Literature Review. J Nippon Med Sch. 2021;88(3):242-7.
4. Yokokawa H, Katsube T, Miyazawa M, Nishiguchi R, Asaka S, Yamaguchi K, et al. First successful case of percutaneous transabdominal thoracic duct embolization (PTTDE) for chylous ascites resulting from laparoscopic gastric cancer surgery. Int Cancer Conf J. 2021;10(2):149-53.
5. Weniger M, D'Haese JG, Angele MK, Kleespies A, Werner J, Hartwig W. Treatment options for chylous ascites after major abdominal surgery: a systematic review. Am J Surg. 2016;211(1):206-13.
6. Takahashi Y, Seki H. Successful management of chylous ascites after pancreatoduodenectomy using etilefrine: a case report. Oxf Med Case Reports. 2020;2020(2):omaa009.
7. Bora Makal G. Lymphatic leakage after laparoscopic sleeve gastrectomy; presentation, management and review of the literature. Ann R Coll Surg Engl. 2020;102(6):e115-e7.
Published
2024-01-11
How to Cite
CASTRO, Bárbara et al. CHYLOPERITONEUM AFTER GASTRECTOMY: IS IT A MANAGEABLE NIGHTMARE?. Revista Portuguesa de Cirurgia, [S.l.], n. 56, p. 89-94, jan. 2024. ISSN 2183-1165. Available at: <https://revista.spcir.com/index.php/spcir/article/view/1012>. Date accessed: 12 july 2024. doi: https://doi.org/10.34635/rpc.1012.
Section
Clinical Case